Filing Flows › Viemed Healthcare (VMD) › Q3 2026 › vs Q3 2025
Viemed Healthcare (VMD) Q3 2026 vs Q3 2025 (year over year)
Viemed Healthcare's revenue rose $8.8M (+12%) from $71.9M in Q3 2025 to $80.7M in Q3 2026. Gross margin 57.3% against 57.5% (-0.2 pts).
Viemed Healthcare, Q3 2026: revenue $80.7M (+12% year over year), operating margin 8.6%, net earnings $4.6M, operating cash flow $11.5M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Gross margin | 57.3% | 57.5% | -0.2 pts |
| Operating margin | 8.6% | 7.8% | +0.8 pts |
| Net margin | 5.7% | 4.9% | +0.9 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $80.7M | $71.9M | $8.8M | +12% |
| Gross profit | $46.2M | $41.3M | $4.8M | +12% |
| Cost of revenue | $34.5M | $30.6M | $3.9M | +13% |
| Operating profit | $7.0M | $5.6M | $1.3M | +23% |
| Operating expenses | $39.2M | $35.7M | $3.5M | +10% |
| Pre-tax earnings | $6.8M | $5.1M | $1.6M | +32% |
| Research & development | $501K | $775K | −$274K | -35% |
| SG&A | $35.5M | $31.9M | $3.6M | +11% |
| Other operating costs | $3.2M | $3.0M | $212K | +7% |
| Net earnings | $4.6M | $3.5M | $1.1M | +32% |
| Minority interests | $99K | $87K | $12K | +14% |
| Income tax | $2.0M | $1.5M | $513K | +33% |
| Depreciation & amortization | $7.7M | $7.5M | $179K | +2% |
| Share-based compensation | $2.5M | $2.2M | $296K | +14% |
| Working capital & other | $3.3M | −$5.1M | $8.5M | — |
| Operating cash flow | $11.5M | $18.4M | −$6.9M | -37% |
Questions
How much did Viemed Healthcare's revenue grow year over year in Q3 2026?
Viemed Healthcare's revenue rose $8.8M (+12%) from $71.9M in Q3 2025 to $80.7M in Q3 2026. Gross margin 57.3% against 57.5% (-0.2 pts).